Stewart Christopher P. 4
4 · Bionano Genomics, Inc · Filed May 27, 2021
Insider Transaction Report
Form 4
Stewart Christopher P.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2021-05-26$0.56/sh+25,000$14,000→ 33,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-26−25,000→ 200,000 totalExercise: $0.56Exp: 2030-09-01→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.